Navigation Links
NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
Date:9/15/2008

PARIS, September 15 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced successful top-line results from the second phase 3 study for naproxcinod in 1020 patients with osteoarthritis of the knee (the 302 study). Both doses of naproxcinod (750 mg and 375 mg bid) met the three co-primary efficacy endpoints at week-13 (p<0.001). The study also comfortably met the main secondary endpoint, demonstrating that naproxcinod 750 mg bid was statistically non-inferior to naproxen 500 mg bid on the WOMAC(TM) pain and function subscales at week-13 and 26. Naproxcinod is the first compound in the new Cyclooxygenase-Inhibiting Nitric Oxide-Donator (CINOD) class of anti-inflammatory agents, which NicOx is developing as a drug for the treatment of the signs and symptoms of osteoarthritis.

NicOx' phase 3 clinical program for naproxcinod consists of three pivotal trials (including the previously completed 301 study in osteoarthritis of the knee and the ongoing 303 study in osteoarthritis of the hip, in addition to the 302 study). Overall, the results of the 302 study support naproxcinod's non-detrimental effect on blood pressure and are consistent with those observed in the 301 study, with naproxcinod 750 mg bid showing a numerical reduction in systolic and diastolic blood pressure at week-13 and 26, compared to baseline and naproxen 500 mg bid. Existing non-steroidal anti-inflammatory agents (NSAIDs) such as ibuprofen and naproxen have the tendency to raise blood pressure, which is a side effect of particular concern in the osteoarthritis population.

A post hoc pooled analysis of the blood pressure data from the 301 and 302 studies showed a statistically significant reduction for naproxcinod 750 mg bid, compared to naproxen 500 mg bid, in terms of the mean change from baseline at week-13, of 2.3 mmHg (p=0.004) for systolic blood pressure and 1.1 mmHg (p=0.034) for diastolic blood pressure. In the planning of the phase 3 program, NicOx had fo
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
2. NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
3. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
4. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
5. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
6. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
9. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
10. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
11. NicOx Naproxcinod ABPM Data Presented at American Heart Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  Today, Levi Ray ... to its PageCenterX ® content management solution. ... to provide downtime reporting capabilities to healthcare organizations ... releasing the product for general availability, effective today. ... experience outages for a variety of reasons," said ...
(Date:7/31/2014)... Calif., July 31, 2014 Cryoport, Inc. (OTCBB: ... period ended June 30, 2014. Recent ... $0.94 million for the three month period ended June ... , Partnered with DHL to further expand Cryoport,s global ... , Advanced support of Immudex, an immunotherapy and ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
Breaking Medicine Technology:LRS Announces Downtime Reporting Solution for Healthcare 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 2Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 3Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 4Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 5Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 6Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 7Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015 8invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... 2011 Ventana Medical Systems, Inc . (Ventana), ... first-of-its-kind integration of the VIRTUOSO digital pathology software and ... integration to the anatomic pathology lab. The ... track the progress of a slide from preparation to ...
... 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... manufacturer and marketer of orthopedic implants in China, today announced ... Bank of America Merrill Lynch New China Conference to be ... JW Marriot Hotel in Beijing, China.  Management is scheduled to ...
Cached Medicine Technology:Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 2Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 3China Kanghui Holdings Announces Participation in Upcoming Investor Conferences 2
(Date:7/31/2014)... Agebc.com, a popular online shop of wedding dresses and women’s ... mother of the bride dresses . Aside from that, ... to 68% off. , “We are proud to enrich ... of the bride dresses. We launch the special offer to ... shop has received thousands of rave reviews from new and ...
(Date:7/31/2014)... ReputationChief.Com, a well-recognized online reputation ... management service named ‘Remove Pissed Consumer’. The service ... rid of Pissed Consumer Complaints. , Remove Pissed ... ReputationChief.Com management assigned the responsibility to vet professionals ... struggling in their social or professional life on ...
(Date:7/31/2014)... The neurovascular interventions market in the ... slowly throughout the forecast period. The neurovascular ... rising prevalence of cerebrovascular disease; the cost ... Medicare, and private health insurance companies; and ... flow diverters and stent retrievers. , Complete ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ethane ... Company, has introduced a new service named ‘Java ... Ethane Web Technologies has designed the service after ... clients and Java Development service being provided by ... company a confidence to promise outstanding Java Development ...
(Date:7/31/2014)... A new catheter being used ... patients who have an abnormal heart rhythm. , ... procedures for patients such as those suffering from ... Heart Specialists were the first in north Florida ... spring, according to Biosense Webster, which develops the ...
Breaking Medicine News(10 mins):Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:ReputationChief.Com Announces a New Online Reputation Management Service 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 5Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3
... by researchers at Wake Forest University Baptist Medical Center is ... weight loss in older adults leads to increased risk of ... intentionally exercised and/or modified their diets to lose weight were ... as their peers who did not work toward weight loss, ...
... give into your child,s meltdowns, expert says , SUNDAY, April ... have a hard time figuring out what to do when ... that kids often have their meltdowns in public places -- ... a Kansas State University child development expert, has compiled tips ...
... or more a week often quit their own jobs, researchers say ... more than 60 hours a week, watch out: His commitment ... , A new study finds that women with husbands who work ... expected to pick up the slack at home in regard to ...
... The law firm of Dussault ... $90,000.00 , ... 2, 2010 -- The law firm of Dussault and Zatir settled out of court a claim ... 92-year-old woman, while walking in her yard, was knocked to the ground by a neighbor’s dog. ...
... ... ... Passover and Easter, a New Jersey physician ventured into the bush country of Haiti. , ... N.J. resident, left at 4 a.m. on Friday, April 2, for a week-long medical mission ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
Cached Medicine News:Health News:Belief that intentional weight loss is harmful to seniors is unfounded 2Health News:Belief that intentional weight loss is harmful to seniors is unfounded 3Health News:Dealing With Those All-Too-Public Tantrums 2Health News:Working Wives Still Expected to Do It All, Study Finds 2Health News:NJ Medical Director Travels To Haiti's Bush Country 2Health News:NJ Medical Director Travels To Haiti's Bush Country 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: